Jpmorgan Chase & CO Intercure Ltd. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Intercure Ltd. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 87,870 shares of INCR stock, worth $176,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,870
Previous 75,750
16.0%
Holding current value
$176,618
Previous $205,000
14.15%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding INCR
# of Institutions
25Shares Held
3.96MCall Options Held
53.1KPut Options Held
200-
Ibex Investors LLC1.89MShares$3.8 Million7.67% of portfolio
-
ETF Managers Group, LLC Summit, NJ811KShares$1.63 Million0.06% of portfolio
-
Toroso Investments, LLC Massapequa, NY460KShares$924,1410.01% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6213KShares$427,1240.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD107KShares$215,9020.04% of portfolio
About Intercure Ltd.
- Ticker INCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,133,900
- Market Cap $90.7M
- Description
- InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...